exendin-4 vs semaglutide Retatrutide Tirzepatide & A. Amino acid sequence comparison
Description
Please read our disclosure for more info

The medications recent links to eye disorders follow findings published in JAMA Ophthalmology about a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) in patients with diabetes treated with semaglutide
Semaglutide is effective for people who have struggled with weight loss in the past

In the head-to-head SURMOUNT-5 trial, tirzepatide achieved 20.2% mean weight reduction compared to 13.7% with semaglutide at 72 weeksa difference of 6.5 percentage points

While Ozempic shares its active ingredient with some weight loss medications, it is not approved for this use

in fact, with a difference of 83% or less (e.g., prevalence of 100% and 17%), it is impossible to reach an IRR OBS of 0.24 regardless of the strength of the association between the confounder and the outcome
